<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Depression.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:54 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="1200006">
<meta name="Category" content="Concern">
<meta name="Article" content="Depression">
<title>Depresi&#243;n-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">Depresi&#243;n</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="Depression.htm">Volver al
art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">Gettis A. Food sensitivities and psychological disturbance: a review. <em>Nutr
Health</em> 1989;6:135&#8211;46.</li>

<li class="Ref">King DS. Can allergic exposure provoke psychological symptoms? A double-blind
test. <em>Biol Psychiatry</em> 1981;16:3&#8211;19.</li>

<li class="Ref">Brown M, Gibney M, Husband PR, Radcliffe M. Food allergy in polysymptomatic
patients. <em>Practitioner</em> 1981;225:1651&#8211;4.</li>

<li class="Ref">Christensen L. Psychological distress and diet-effects of sucrose and
caffeine. <em>J Applied Nutr</em> 1988;40:44&#8211;50.</li>

<li class="Ref">Greden JF, Fontaine P, Lubetsky M, Chamberlin K. Anxiety and depression
associated with caffeinism among psychiatric inpatients. <em>Am J Psychiatry</em>
1978;135:963&#8211;6.</li>

<li class="Ref">Kawachi I, Willett WC, Colditz GA, et al. A prospective study of coffee
drinking and suicide in women. <em>Arch Intern Med</em> 1996;156:521&#8211;5.</li>

<li class="Ref">Gilliland K, Bullock W. Caffeine: a potential drug of abuse. <em>Adv Alcohol
Subst Abuse</em> 1983&#8211;84;3:53&#8211;73.</li>

<li class="Ref">Weber B, Schweiger U, Deuschle M, Heuser I. Major depression and impaired
glucose tolerance. <em>Exp Clin Endocrinol Diabetes</em> 2000;108:187&#8211;90.</li>

<li class="Ref">Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and
mortality: a quantitative review of primary prevention trials. <em>BMJ</em>
1990;301:309&#8211;14.</li>

<li class="Ref">Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary
events after myocardial infarction in patients with average cholesterol levels. Cholesterol
and Recurrent Events Trial investigators. <em>N Engl J Med</em> 1996;335:1001&#8211;9.</li>

<li class="Ref">Wardle J, Armitage J, Collins R, et al. Randomised placebo controlled trial of
effect on mood of lowering cholesterol concentration. Oxford Cholesterol Study Group. <em>
BMJ</em> 1996;313:75&#8211;8.</li>

<li class="Ref">Hibbeln JR, Salem N Jr. Dietary polyunsaturated fatty acids and depression:
when cholesterol does not satisfy. <em>Am J Clin Nutr</em> 1995;62:1&#8211;9 [review].</li>

<li class="Ref">Makiya H. Epidemiological investigation of psychiatric disorders of old age in
Sashiki-village, Okinawa. <em>Keio J Med</em> 1978;55:503.</li>

<li class="Ref">O&#8217;Hara MW, Kohout FJ, Wallace RB. Depression among the rural elderly. A
study of prevalence and correlates. <em>J Nerv Ment Dis</em> 1985;173:582&#8211;9.</li>

<li class="Ref">Krause N, Liang J. Cross-cultural variations in depressive symptoms in later
life. <em>Int Psychogeriatr</em> 1992;4(Suppl 2):185&#8211;202.</li>

<li class="Ref">Iribarren C, Reed DM, Wergowske G, et al. Serum cholesterol level and
mortality due to suicide and trauma in the Honolulu Heart Program. <em>Arch Intern Med</em>
1995;155:695&#8211;700.</li>

<li class="Ref">Martinsen EW. Benefits of exercise for the treatment of depression. <em>Sports
Med</em> 1990;9:380&#8211;9.</li>

<li class="Ref">Martinsen EW, Medhus A, Sandivik L. Effects of aerobic exercise on depression:
a controlled study. <em>BMJ</em> 1985;291:109.</li>

<li class="Ref">Blumenthal JA, Babyak MA, Moore KA, et al. Effects of exercise training on
older patients with major depression. <em>Arch Intern Med</em> 1999;159:2349&#8211;56.</li>

<li class="Ref">Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused
by cobalamin deficiency in the absence of anemia or macrocytosis. <em>N Engl J Med</em>
1988;318:1720&#8211;8.</li>

<li class="Ref">Penninx BW, Guralnik JM, Ferrucci L, et al. Vitamin B(12) deficiency and
depression in physically disabled older women: epidemiologic evidence from the Women&#8217;s
Health and Aging Study. <em>Am J Psychiatry</em> 2000;157:715&#8211;21.</li>

<li class="Ref">Holmes JM. Cerebral manifestations of vitamin B12 deficiency. <em>J Nutr
Med</em> 1991;2:89&#8211;90.</li>

<li class="Ref">Ellis FR, Nasser S. A pilot study of vitamin B12 in the treatment of
tiredness. <em>Br J Nutr</em> 1973;30:277&#8211;83.</li>

<li class="Ref">Reynolds E, Preece JM, Bailey J, Coppen A. Folate deficiency in depressive
illness. <em>Br J Psychiatry</em> 1970;117:287&#8211;92.</li>

<li class="Ref">Coppen A, Chaudrhy S, Swade C. Folic acid enhances lithium prophylaxis. <em>J
Affect Disord</em> 1986;10:9&#8211;13.</li>

<li class="Ref">Di Palma C, Urani R, Agricola R, et al. Is methylfolate effective in relieving
major depression in chronic alcoholics? A hypothesis of treatment. <em>Curr Ther Res</em>
1994;55:559&#8211;67.</li>

<li class="Ref">Barkai AI, Dunner DL, Gross HA, et al. Reduced myo-inositol levels in
cerebrospinal fluid from patients with affective disorder. <em>Biol Psychiatry</em>
1978;13:65&#8211;72.</li>

<li class="Ref">Levine J, Rapaport A, Lev L. Inositol treatment raises CSF inositol levels.
<em>Brain Res</em> 1993;627:168&#8211;70.</li>

<li class="Ref">Levine J, Barak Y, Gonzalves M, et al. Double-blind, controlled trial of
inositol treatment of depression. <em>Am J Psychiatry</em> 1995;152:792&#8211;4.</li>

<li class="Ref">Levine J, Barak Y, Kofman O, Belmaker RH. Follow-up and relapse analysis of an
inositol study of depression. <em>Isr J Psychiatry Relat Sci</em> 1995;32:14&#8211;21.</li>

<li class="Ref">Adams PW, Wynn V, Rose DP, et al. Effect of pyridoxine hydrochloride (Vitamin
B6) upon depression associated with oral contraception. <em>Lancet</em>
1973;1:897&#8211;904.</li>

<li class="Ref">Russ CS, Hendricks TA, Chrisley BM, et al. Vitamin B-6 status of depressed and
obsessive-compulsive patients. <em>Nutr Rep Int</em> 1983;27:867&#8211;73.</li>

<li class="Ref">Gunn ADG. Vitamin B6 and the premenstrual syndrome (PMS). <em>Int J Vitam Nutr
Res</em> 1985;(Suppl 27):213&#8211;24 [review].</li>

<li class="Ref">Kleijnen J, Riet GT, Knipschild P. Vitamin B6 in the treatment of the
premenstrual syndrome&#8212;a review. <em>Br J Obstet Gynaecol</em> 1990;97:847&#8211;52.</li>

<li class="Ref">Finley JW, Penland JG. Adequacy or deprivation of dietary selenium in healthy
men: Clinical and psychological findings. <em>J Trace Elem Exp Med</em>
1998;11:11&#8211;27.</li>

<li class="Ref">Benton D, Cook R. The impact of selenium supplementation on mood. <em>Biol
Psychiatry</em> 1991;29:1092&#8211;8.</li>

<li class="Ref">Lansdowne ATG, Provost SC. Vitamin D3 enhances mood in healthy subjects during
winter. <em>Psychopharmacology</em> 1998;135:319&#8211;23.</li>

<li class="Ref">Arasteh K. A beneficial effect of calcium intake on mood. <em>J Orthomolec
Med</em> 1994;9:199&#8211;204.</li>

<li class="Ref">Edwards R, Peet M, Shay J, Horrobin D. Omega-3 polyunsaturated fatty acid
levels in the diet and in red blood cell membranes of depressed patients. <em>J Affect
Disord</em> 1998;48:149&#8211;55.</li>

<li class="Ref">Maes M, Smith R, Christophe A, et al. Fatty acid composition in major
depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega
6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. <em>J Affect Disord</em>
1996;38:35&#8211;46.</li>

<li class="Ref">Peet M, Murphy B, Shay J, Horrobin D. Depletion of omega-3 fatty acid levels
in red blood cell membranes of depressive patients. <em>Biol Psychiatry</em>
1998;43:315&#8211;9.</li>

<li class="Ref">Maes M, Christophe A, Delanghe J, et al. Lowered omega-3 polyunsaturated fatty
acids in serum phospholipids and cholesteryl esters of depressed patients. <em>Psychiatry
Res</em> 1999;85:275&#8211;91.</li>

<li class="Ref">Adams PB, Lawson S, Sanigorski A, Sinclair AJ. Arachidonic acid to
eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of
depression. <em>Lipids</em> 1996;31:S157&#8211;S161.</li>

<li class="Ref">Stoll AL, Severus WE, Freeman MP, et al. Omega 3 fatty acids in bipolar
disorder. A preliminary double-blind, placebo-controlled trial. <em>Arch Gen Psychiatry</em>
1999;56:407&#8211;12.</li>

<li class="Ref">Puri BK, Counsell SJ, Richardson AJ, Horrobin DF. Eicosapentaenoic acid in
treatment-resistant depression. <em>Arch Gen Psychiatry</em> 2002;59:91&#8211;92
[Letter].</li>

<li class="Ref">Peet M, Horrobin DF. A dose-ranging study of the effects of
ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate
treatment with standard drugs. <em>Arch Gen Psychiatry</em> 2002;59:913&#8211;9.</li>

<li class="Ref">Rose DP, Cramp DG. Reduction of plasma tyrosine by oral contraceptives and
oestrogens: a possible consequence of tyrosine aminotransferase induction. <em>Clin Chim
Acta</em> 1970;29:49&#8211;53.</li>

<li class="Ref">Moller SE. Tryptophan and tyrosine availability and oral contraceptives. <em>
Lancet</em> 1979;2:472 [letter].</li>

<li class="Ref">Kishimoto H, Hama Y. The level and diurnal rhythm of plasma tryptophan and
tyrosine in manic-depressive patients. <em>Yokohama Med Bull</em> 1976;27:89&#8211;97.</li>

<li class="Ref">Gelenberg AJ, Wojcik JD, Growdon JH, et al. Tyrosine for the treatment of
depression. <em>Am J Psychiatry</em> 1980;137:622&#8211;3.</li>

<li class="Ref">Sabelli HC, Fawcett J, Gustovsky F, et al. Clinical studies on the
phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and
phenylalanine dietary supplements. <em>J Clin Psychiatry</em> 1986;47:66&#8211;70.</li>

<li class="Ref">Sabelli HC, Fawcett J, Gustovsky F, et al. Clinical studies on the
phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and
phenylalanine dietary supplements. <em>J Clin Psychiatry</em> 1986;47:66&#8211;70.</li>

<li class="Ref">Beckmann H, Strauss MA, Ludolph E. DL-Phenylalanine in depressed patients: an
open study. <em>J Neural Transm</em> 1977;41:123&#8211;34.</li>

<li class="Ref">Beckmann H, Athen D, Olteanu M, Zimmer R. DL-phenylalanine versus imipramine:
a double-blind controlled study. <em>Arch Psychiatr Nervenkr</em> 1979;227:49&#8211;58.</li>

<li class="Ref">Tempesta E, Casella L, Pirrongelli C, et al. L-acetylcarnitine in depressed
elderly subjects. A cross-over study vs placebo. <em>Drugs Exp Clin Res</em>
1987;13:417&#8211;23.</li>

<li class="Ref">Garzya G, Corallo D, Fiore A, et al. Evaluation of the effects of
L-acetylcarnitine on senile patients suffering from depression. <em>Drugs Exp Clin Res</em>
1990;16:101&#8211;6.</li>

<li class="Ref">Guarnaschelli C, Fugazza G, Pistarini C. Pathological brain ageing: evaluation
of the efficacy of a pharmacological aid. <em>Drugs Exp Clin Res</em>
1988;14:715&#8211;8.</li>

<li class="Ref">Bella R, Biondi R, Raffaele R, Pennisi G. Effect of acetyl-L-carnitine on
geriatric patients suffering from dysthymic disorders. <em>Int J Clin Pharmacol Res</em>
1990;10:355&#8211;60.</li>

<li class="Ref">Barrett-Connor E, von M&#252;hlen D, Laughlin GA, Kripke A. Endogenous levels
of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed
mood in older women: The Rancho Bernardo Study. <em>J Am Geriatr Soc</em>
1999;47:685&#8211;91.</li>

<li class="Ref">Heuser I, Deuschle M, Luppa P, et al. Increased diurnal plasma concentrations
of dehydroepiandrosterone in depressed patients. <em>J Clin Endocrinol Metab</em>
1998;83:3130&#8211;3.</li>

<li class="Ref">Morales AJ, Nolan JJ, Nelson JC, Yen SSC. Effects of replacement dose of DHEA
in men and women of advancing age. <em>J Clin Endorcrionol Metab</em> 1994;78:1360.</li>

<li class="Ref">Wolkowitz OM, Reus VI, Keebler A, et al. Double-blind treatment of major
depression with dehydroepiandrosterone. <em>Am J Psychiatry</em> 1999;156:646&#8211;9.</li>

<li class="Ref">Bloch M, Schmidt PJ, Danaceau MA, et al. Dehydroepiandrosterone treatment of
midlife dysthymia. <em>Biol Psychiatry</em> 1999;45:1533&#8211;41.</li>

<li class="Ref">Wolf OT, Neumann O, Hellhammer DH, et al. Effects of a two-week physiological
dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly
women and men. <em>J Clin Endocrinol Metab</em> 1997;82:2263&#8211;7.</li>

<li class="Ref">Gaby AR. Research review. <em>Nutr Healing</em> 1997;8.</li>

<li class="Ref">Lewy AJ, Bauer VK, Cutler NL, Sack RL. Melatonin treatment of winter
depression: a pilot study. <em>Psychiatr Res</em> 1998;77:57&#8211;61.</li>

<li class="Ref">Dolberg OT, Hirschmann S, Grunhaus L. Melatonin for the treatment of sleep
disturbances in major depressive disorder. <em>Am J Psychiatry</em>
1998;155:1119&#8211;21.</li>

<li class="Ref">Bell KM, Potkin SG, Carreon D, Plon L. S-adenosylmethionine blood levels in
major depression: changes with drug treatment. <em>Acta Neurol Scand</em>
1994;154(suppl):15&#8211;8.</li>

<li class="Ref">Bressa GM. S-adenosyl-l-methionine (SAMe) as antidepressant: Meta-analysis of
clinical studies<em>. Acta Neurol Scand</em> 1994;154(suppl):7&#8211;14.</li>

<li class="Ref">Salmaggi P, Bressa GM, Nicchia G, et al. Double-blind, placebo-controlled
study of s-adenosyl-methionine in depressed postmenopausal women. <em>Psychother
Psychosom</em> 1993;59:34&#8211;40.</li>

<li class="Ref">Kagan BL, Sultzer DL, Rosenlicht N, et al. Oral S-adenosyl-methionine in
depression: A randomized, double-blind, placebo-controlled trial. <em>Am J Psychiatry</em>
1990;147:591&#8211;5.</li>

<li class="Ref">Fava M, Rosenbaum JF, Birnbaum R, et al. The thyrotropin-releasing hormone as
a predictor of response to treatment in depressed outpatients. <em>Acta Psychiatr Scand</em>
1992;86:42&#8211;5.</li>

<li class="Ref">De Vanna M, Rigamonti R. Oral S-adenosyl-L-methionine in depression. <em>Curr
Ther Res</em> 1992;52:478&#8211;85.</li>

<li class="Ref">Van Praag HM, Lemus C. Monoamine precursors in the treatment of psychiatric
disorders. <em>Nutrition and the Brain,</em> vol. 7, RJ Wurtman, JJ Wurtman, eds. New York:
Raven Press, 1986 [review].</li>

<li class="Ref">Van Praag H, de Hann S. Depression vulnerability and 5-hydroxytryptophan
prophylaxis. <em>Psychiatry Res</em> 1980;3:75&#8211;83.</li>

<li class="Ref">Angst J, Woggon B, Schoepf J. The treatment of depression with
L-5-hydroxytryptophan versus imipramine. Results of two open and one double-blind study. <em>
Arch Psychiatr Nervenkr</em> 1977;224:175&#8211;86.</li>

<li class="Ref">Nolen WA, van de Putte JJ, Dijken WA, et al. Treatment strategy in depression.
II. MAO inhibitors in depression resistant to cyclic antidepressants: two controlled crossover
studies with tranylcypromine versus L-5-hydroxytryptophan and nimifensine. <em>Acta Psychiatr
Scand</em> 1988;78:676&#8211;83.</li>

<li class="Ref">Nolen WA, van de Putte JJ, Dijken WA, Kamp JS. L-5-HTP in depression resistant
to re-uptake inhibitors. An open comparative study with tranylcypromine. <em>Br J
Psychiatry</em> 1985;147:16&#8211;22.</li>

<li class="Ref">D&#8217;Elia G, Hanson L, Raotma H. L-tryptophan and 5-hydroxytryptophan in
the treatment of depression. A review. <em>Acta Psychiatr Scand</em> 1978;57:239&#8211;52
[review].</li>

<li class="Ref">McLeod MN, Gaynes BN, Golden RN. Chromium potentiation of antidepressant
pharmacotherapy for dysthymic disorder in 5 patients. <em>J Clin Psychiatry</em>
1999;60:237&#8211;40.</li>

<li class="Ref">Maggioni M, Picotti GB, Bondiolotti GP, et al. Effects of phosphatidylserine
therapy in geriatric patients with depressive disorders. <em>Acta Psychiatr Scand</em>
1990;81:265&#8211;70.</li>

<li class="Ref">Birkmayer JGD, Birkmayer W. The coenzyme nicotinamide adenine dinucleotide
(NADH) as biological antidepressive agent: Experience with 205 patients. <em>New Trends Clin
Neuropharmacol</em> 1991;5:19&#8211;25.</li>

<li class="Ref">Harrer G, Sommer H. Treatment of mild/moderate depressions with Hypericum.
<em>Phytomedicine</em> 1994;1:3&#8211;8.</li>

<li class="Ref">Ernst E. St. John&#8217;s wort, an antidepressant? A systemic, criteria-based
review. <em>Phytomedicine</em> 1995;2:67&#8211;71.</li>

<li class="Ref">Vorbach EU, H&#252;bner WD, Arnoldt KH. Effectiveness and tolerance of the
Hypericum extract LI 160 in comparison with imipramine: Randomized double-blind study with 135
outpatients. <em>J Geriatr Psychiatry Neurol</em> 1994;7(suppl):S19&#8211;23.</li>

<li class="Ref">Philipp M, Kohnen R, Hiller KO. Hypericum extract versus imipramine or placebo
in patients with moderate depression: randomized multicenter study of treatment for eight
weeks. <em>BMJ</em> 1999;319:1534&#8211;9.</li>

<li class="Ref">Woelk H. Comparison of St. John&#8217;s wort and imipramine for treating
depression: Randomized controlled trial. <em>BMJ</em> 2000;321:536&#8211;9.</li>

<li class="Ref">Wheatley D. LI 160, an extract of St. John&#8217;s wort versus amitriptyline
in mildly to moderately depressed outpatients&#8212;controlled six week clinical trial. <em>
Pharmacopsychiatry</em> 1997;30(suppl):77&#8211;80.</li>

<li class="Ref">Volz HP, Laux P. Potential treatment for subthreshold and mild depression: a
comparison of St. John&#8217;s wort extracts and fluoxetine. <em>Compr Psychiatry</em>
2000;41(2 Suppl 1):133&#8211;7 [review].</li>

<li class="Ref">Harrer G, H&#252;bner WD, Poduzweit H. Effectiveness and tolerance of the
Hypericum extract LI 160 compared to maprotiline: A multicenter double-blind study. <em>J
Geriatr Psychiatry Neurol</em> 1994;7(suppl 1);S24&#8211;8.</li>

<li class="Ref">Harrer G, Schmidt U, Kuhn U, Biller A. Comparison of equivalence between the
St. John&#8217;s wort extract LoHyp-57 and fluoxetine. <em>Arzneimittelforschung</em>
1999;49:289&#8211;96.</li>

<li class="Ref">Schrader D. Equivalence of St. John&#8217;s wort extract (ZE 117) and
fluoxetine: a randomized, controlled study in mild &#8211; moderate depression. <em>
International Clin Psychopharmacol</em> 2000;15:61&#8211;8.</li>

<li class="Ref">Vorbach EU, Arnoldt KH, H&#252;bner WD. Efficacy and tolerability of St.
John&#8217;s wort extract LI 160 versus imipramine in patients with severe depressive episodes
according to ICD-10. <em>Pharmacopsychiatry</em> 1997;30(suppl):81&#8211;5.</li>

<li class="Ref">Shelton RC, Keller MB, Gelenberg A, et al. Effectiveness of St John's wort in
major depression: a randomized controlled trial. <em>JAMA</em> 2001;285:1978&#8211;86.</li>

<li class="Ref">Hypericum Depression Trial Study Group. Effect of <em>Hypericum
perforatum</em> (St John's Wort) in major depressive disorder: a randomized controlled trial.
<em>JAMA</em> 2002;287:1807&#8211;14.</li>

<li class="Ref">Schubert H, Halama P. Depressive episode primarily unresponsive to therapy in
elderly patients; efficacy of Ginkgo biloba extract (EGb 761) in combination with
antidepressants. <em>Geriatr Forsch</em> 1993;3:45&#8211;53.</li>

<li class="Ref">Cohen AJ, Bartlik B. <em>Ginkgo biloba</em> for antidepressant-induced sexual
dysfunction. <em>J Sex Marital Therapy</em> 1998;24:139&#8211;45.</li>

<li class="Ref">Eagles JM. Treatment of depression with pumpkin seeds. <em>Br J
Psychiatry</em> 1990;157:937&#8211;8.</li>

<li class="Ref">Han JS. Electroacupuncture: an alternative to antidepressants for treating
affective diseases? <em>Int J Neurosci</em> 1986;29:79&#8211;92.</li>

<li class="Ref">Hechun L, Yunkui J, Li Z. Electro-acupuncture vs amitriptyline in the
treatment of depressive states. <em>J Tradit Chin Med</em> 1985;5:3&#8211;8.</li>

<li class="Ref">Xiang L, Hechun L, Yunkui J. Clinical observation on needling extrachannel
points in treating mental depression. <em>J Tradit Chin Med</em> 1994;14:14&#8211;8.</li>

<li class="Ref">Luo H, Meng F, Jia Y, Zhao X. Clinical research on the therapeutic effect of
the electro acupuncture treatment in patients with depression. <em>Psychiatry Clin
Neurosci</em> 1998;52:S338&#8211;S340.</li>

<li class="Ref">Roschke J, Wolf C, Kogel P, et al. Adjuvant whole body acupuncture in
depression. A placebo-controlled study with standardized mianserin therapy. <em>
Nervenarzt</em> 1998;69:961&#8211;7 [in German].</li>

<li class="Ref">Niklson IA, Reimitz PE, Sennef C. Factors that influence the outcome of
placebo-controlled antidepressant clinical trials. <em>Psychopharmacol Bull</em>
1997;33:41&#8211;51.</li>

<li class="Ref">DeRubeis RJ, Gelfand LA, Tang TZ, Simons AD. Medications versus cognitive
behaviour therapy for severely depressed outpatients: mega-analysis of four randomized
comparisons. <em>Am J Psychiatry</em> 1999;156:1007&#8211;13.</li>

<li class="Ref">Janakiramaiah N, Gangadhar BN, Naga Venkatesha Murthy PJ, et al.
Antidepressant efficacy of Sudarshan Kriya Yoga (SKY) in melancholia: a randomized comparison
with electroconvulsive therapy (ECT) and imipramine. <em>J Affect Disord</em>
2000;57:255&#8211;9.</li>

<li class="Ref">Berman RM, Narasimhan M, Sanacora G, et al. A randomized clinical trial of
repetitive transcranial magnetic stimulation in the treatment of major depression. <em>Biol
Psychiatry</em> 2000;47:332&#8211;7.</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Depression.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:54 GMT -->
</html>

